Effects of a Supplement on Acute Respiratory Infections
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Barbara Vizmanos-Lamotte, M.D., Ph.D
University of Guadalajara
Principal Investigator - Elvia Silva-Villanueva, M.Sc.(O.H).
Omnilife Manufactura, SA de CV
Principal Investigator - Gabriela Macedo-Ojeda, Ph.D.
University of Guadalajara
Principal Investigator - Margarita Posada-Falomir, B.Sc.(Nutr.)
Omnilife Manufactura, SA de CV
Principal Investigator - María F. Bernal-Orozco, Ph.D.
Omnilife Manufactura, SA de CV
Study Director - Rafael Ortega-Orozco, M.D.
Omnilife Manufactura, SA de CV
Principal Investigator - Yolanda F. Marquez-Sandoval, Ph.D.
University of Guadalajara
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Omnilife
Guadalajara, Jalisco, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2012
- Primary completion
- 30 Apr 2012
- Completion
- 30 Apr 2012
- Last update posted
- 7 Aug 2014
- Registered enrollment
- 45
- Registry id
- NCT02210156
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.